Development and Readiness Pilot (CDRP) program supports the acceleration of manufacturing readiness for therapies with ...
The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...
Valion Bio, Inc. (Nasdaq: VBIO) (formerly Tivic Health Systems, Inc.), a clinical-stage immunotherapeutics company developing Entolimod™ for Acute Radiation Syndrome (ARS) and oncology supportive care ...
ICOTYDE™ (icotrokinra) approved by FDA in March for moderate-to-severe plaque psoriasis, triggering a $50 million ...
The FDA’s Office of Women’s Health, in partnership with the FDA’s Human Foods Program, is hosting a webinar during National ...
Seattle could be mulling changes to its drug ordinance after new data showed a 30% drop in referrals to the Law Enforcement ...
Stroke drug developer Argenica Therapeutics plans a second trial to test its novel candidate, in a sector that has few ...
Texas is helping shape the future of psychedelic therapies. Here's how they work and what access could look like.
A federal appeals court judge appeared skeptical Tuesday of a lawsuit from Teva Pharmaceuticals Inc. challenging the US ...
Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results